FGC
WST icon

Financial Gravity Companies’s West Pharmaceutical WST Stock Holding History

Financial Gravity Companies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$8K Buy
+76
New +$8.25K 0.01% 641

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Financial Gravity Companies's WST Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in West Pharmaceutical (WST) in Q4 2018: 76 shares worth $8K. The stake represents 0.01% of the portfolio and ranks #641 among its holdings.

355 funds tracked by Wall St. Rank hold WST as of Q4 2018.

  • Financial Gravity Companies held 76 shares of West Pharmaceutical worth $8K as of Q4 2018.
  • West Pharmaceutical was a new Financial Gravity Companies position in Q4 2018.
  • West Pharmaceutical made up 0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #641 holding.
  • 355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.